Related Experiment Video
Updated: Aug 10, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
HSP27 inhibits cytochrome c-dependent activation of procaspase-9
C Garrido1, J M Bruey, A Fromentin
1INSERM U517, Groupe Biologie et Thérapie des Cancers (JE 515), Faculty of Medicine and Pharmacy, 21033 Dijon, France. cgarrido@u-bourgogne.fr
Abstract:
We have previously shown that the small heat shock protein HSP27 inhibited apoptotic pathways triggered by a variety of stimuli in mammalian cells. The present study demonstrates that HSP27 overexpression decreases U937 human leukemic cell sensitivity to etoposide-induced cytotoxicity by preventing apoptosis. As observed for Bcl-2, HSP27 overexpression delays poly(ADP-ribose)polymerase cleavage and procaspase-3 activation. In contrast with Bcl-2, HSP27 overexpression does not prevent etoposide-induced cytochrome c release from the mitochondria. In a cell-free system, addition of cytochrome c and dATP to cytosolic extracts from untreated cells induces the proteolytic activation of procaspase-3 in both control and bcl-2-transfected U937 cells but fails to activate procaspase-3 in HSP27-overexpressing cells. Immunodepletion of HSP27 from cytosolic extracts increases cytochrome c/dATP-mediated activation of procaspase-3. Overexpression of HSP27 also prevents procaspase-9 activation. In the cell-free system, immunodepletion of HSP27 increases LEDH-AFC peptide cleavage activity triggered by cytochrome c/dATP treatment. We conclude that HSP27 inhibits etoposide-induced apoptosis by preventing cytochrome c and dATP-triggered activity of caspase-9, downstream of cytochrome c release.
Insights
Small heat shock protein HSP27 prevents programmed cell death (apoptosis) in human leukemic cells. HSP27 inhibits caspase-9 activation, a key step in the apoptotic pathway, making cells less sensitive to chemotherapy drugs like etoposide.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Small heat shock protein HSP27 has been shown to inhibit apoptotic pathways in mammalian cells.
- Understanding the mechanisms by which HSP27 modulates apoptosis is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of HSP27 in etoposide-induced apoptosis in U937 human leukemic cells.
- To elucidate the specific molecular mechanisms by which HSP27 confers resistance to apoptosis.
Main Methods:
- Overexpression of HSP27 in U937 cells.
- Assessment of etoposide-induced cytotoxicity and apoptosis.
- Analysis of poly(ADP-ribose)polymerase cleavage and procaspase-3 activation.
- Measurement of cytochrome c release from mitochondria.
- Cell-free assays to study caspase activation in response to cytochrome c and dATP.
- Immunodepletion techniques to assess the role of HSP27 in caspase activation.
Main Results:
- HSP27 overexpression decreased U937 cell sensitivity to etoposide-induced cytotoxicity by preventing apoptosis.
- HSP27 delayed poly(ADP-ribose)polymerase cleavage and procaspase-3 activation, similar to Bcl-2.
- Unlike Bcl-2, HSP27 did not prevent etoposide-induced cytochrome c release.
- In cell-free systems, HSP27 inhibited cytochrome c/dATP-mediated activation of procaspase-3 and procaspase-9.
- Immunodepletion of HSP27 restored caspase activation in cell-free extracts.
Conclusions:
- HSP27 inhibits etoposide-induced apoptosis by preventing the activation of caspase-9, downstream of cytochrome c release.
- HSP27 acts as a critical inhibitor of the intrinsic apoptotic pathway at the level of caspase-9 activation.
Related Concept Videos
Inhibition of Cdk Activity
Anaphase Promoting Complex
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

